Finished product reference
Adult Cold Preparations (4-9)
Capsule, Liquid Filled · Oral · 250 mg/12.5 mg/5 mg
- List code
- 52625
- Pharmacologic class
- Combination cold and flu preparations (category)
What it is and how it works
A category of over-the-counter fixed-dose combinations for adults, in tablet, capsule or powder (hot drink) form, typically combining an analgesic-antipyretic such as paracetamol with variable amounts of an antihistamine, a nasal decongestant, an antitussive or expectorant, caffeine and/or vitamin C. The components act on separate symptoms of upper respiratory tract infection.
Indications
Short-term symptomatic relief of common cold and influenza symptoms in adults, including fever, headache, aches, nasal congestion, rhinorrhoea and cough.
Contraindications
Depend on the components; commonly hypersensitivity, severe hypertension or coronary disease, use with MAO inhibitors and severe hepatic impairment.
Warnings and precautions
Composition varies between products; avoid concomitant use of other paracetamol-, NSAID- or decongestant-containing medicines. Products with sedating antihistamines cause drowsiness. Use for more than a few days or in chronic cardiovascular, thyroid, prostatic or ocular disease requires medical advice.
Pregnancy
Generally avoided in pregnancy unless advised by a physician.
Storage and supply
Store below 25 °C in a dry place, protected from light.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
- Tablet · Oral · 500 mg/5 mg7216
- Tablet · Oral · 325 mg/5 mg50342
- Capsule, Liquid Filled · Oral · 200 mg/5 mg15465
- Powder, for Solution · Oral · 650 mg/10 mg52417
- Tablet · Oral · 500 mg/10 mg52807
- Tablet · Oral · 500 mg/25 mg21373
- Tablet · Oral · 325 mg/2 mg52754
- Tablet · Oral · 500 mg/5 mg/25 mg52368
- Capsule, Liquid Filled · Oral · 325 mg/2 mg/5 mg13710
- Powder, for Solution · Oral · 650 mg/10 mg/25 mg52416
- Powder, for Solution · Oral · 500 mg/10 mg/4 mg52701
- Tablet · Oral · 650 mg/10 mg/4 mg50348
- Tablet · Oral · 325 mg/5 mg/2 mg5951
- Tablet · Oral · 325 mg/10 mg/25 mg51965
- Tablet · Oral · 325 mg/30 mg/25 mg52055
- Tablet · Oral · 500 mg/10 mg/25 mg52071
- Tablet · Oral · 500 mg/5 mg/2 mg52197
- Tablet · Oral · 325 mg/15 mg/5 mg11045
- Capsule, Liquid Filled · Oral · 500 mg/10 mg/5 mg21667
- Tablet · Oral · 500 mg/15 mg/5 mg52327
- Powder, for Solution · Oral · 650 mg/20 mg/10 mg52419
- Tablet · Oral · 15 mg/5 mg/325 mg52725
- Tablet · Oral · 300 mg/15 mg/2 mg52442
- Tablet · Oral · 15 mg/2 mg/30 mg/325 mg52904
- Capsule, Liquid Filled · Oral · 10 mg/2 mg/5 mg/500 mg50580
- Tablet · Oral · 15 mg/2 mg/5 mg/325 mg52903
- Tablet · Oral · 15 mg/2 mg/5 mg/500 mg51952
- Capsule, Liquid Filled · Oral · 15 mg/2 mg/5 mg/325 mg50563
- Capsule, Liquid Filled · Oral · 15 mg/2 mg/5 mg/500 mg50564
- Tablet · Oral · 325 mg/15 mg/200 mg/5 mg18466
- Tablet · Oral · 325 mg/10 mg/100 mg/5 mg53113
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.